SANOFI PASTEUR

Sanofi offers a range of quadrivalent flu vaccines that help provide active immunization to prevent disease caused by influenza A subtype type B viruses. Please see Important Safety Information or Prescribing Information... In a randomized, controlled efficacy trial, Flublok Quadrivalent provided 30% (95% CI: 10-47) better protection against influenza due to any PCR-confirmed circulating strains vs a standard-dose quadrivalent inactivated influenza vaccine in adults 50 years of age and older. 2,4

Also known as: Protein Sciences Corporation, Sanofi Pasteur Inc